AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,080,540 | -8.6% | 171,097 | -5.6% | 0.03% | 0.0% |
| Q2 2023 | $2,276,952 | +5.2% | 181,286 | -7.1% | 0.03% | 0.0% |
| Q1 2023 | $2,164,114 | -13.2% | 195,141 | -4.4% | 0.03% | -16.1% |
| Q4 2022 | $2,492,513 | +18.5% | 204,137 | +1.4% | 0.03% | +10.7% |
| Q3 2022 | $2,103,000 | +6.0% | 201,398 | +9.0% | 0.03% | +12.0% |
| Q2 2022 | $1,984,000 | +12.5% | 184,775 | -0.7% | 0.02% | +31.6% |
| Q1 2022 | $1,763,000 | -21.4% | 186,164 | -4.2% | 0.02% | -17.4% |
| Q4 2021 | $2,244,000 | +19.8% | 194,264 | -0.9% | 0.02% | +21.1% |
| Q3 2021 | $1,873,000 | -2.3% | 196,081 | -1.4% | 0.02% | 0.0% |
| Q2 2021 | $1,918,000 | -6.4% | 198,912 | -4.1% | 0.02% | -9.5% |
| Q1 2021 | $2,050,000 | -59.4% | 207,464 | -5.2% | 0.02% | -63.2% |
| Q4 2020 | $5,055,000 | +76.0% | 218,917 | +7.6% | 0.06% | +50.0% |
| Q3 2020 | $2,872,000 | -20.1% | 203,409 | -14.6% | 0.04% | -25.5% |
| Q2 2020 | $3,593,000 | +95.4% | 238,254 | +19.7% | 0.05% | +64.5% |
| Q1 2020 | $1,839,000 | -9.1% | 199,066 | -4.2% | 0.03% | +19.2% |
| Q4 2019 | $2,024,000 | +20.6% | 207,831 | -0.7% | 0.03% | +13.0% |
| Q3 2019 | $1,678,000 | -36.1% | 209,241 | -0.6% | 0.02% | -37.8% |
| Q2 2019 | $2,626,000 | -8.2% | 210,406 | +0.1% | 0.04% | -11.9% |
| Q1 2019 | $2,860,000 | +44.6% | 210,268 | +1.8% | 0.04% | +27.3% |
| Q4 2018 | $1,978,000 | -20.8% | 206,449 | 0.0% | 0.03% | -5.7% |
| Q3 2018 | $2,496,000 | -23.2% | 206,449 | -0.7% | 0.04% | -27.1% |
| Q2 2018 | $3,248,000 | +3.8% | 207,960 | 0.0% | 0.05% | 0.0% |
| Q1 2018 | $3,128,000 | +4.5% | 207,960 | 0.0% | 0.05% | +4.3% |
| Q4 2017 | $2,993,000 | +153.2% | 207,960 | +165.3% | 0.05% | +142.1% |
| Q3 2017 | $1,182,000 | – | 78,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |